| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $539,332 ) |
| | 2024 | 2024 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01AI140303 | Gut Microbiota and Effect on Immune Suppressants in Transplantation | 000 | 5 | NIH | 1/16/2024 | $591,663 |
| | 2024 | 2024 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01DK134482 | Shared decision making for kidney transplant candidates to plan for an organ offer decision | 000 | 2 | NIH | 11/21/2023 | $245,833 |
| | 2024 | 2024 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01DK135730 | Virtual coaching for potential kidney transplant candidates and their social support networks | 000 | 2 | NIH | 1/29/2024 | $237,683 |
| | 2024 | 2024 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 002 | 10 | NIH | 4/24/2024 | $1 |
| | 2024 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | U19AG062682 | ASPirin in Reducing Events in the Elderly - eXTension | 000 | 5 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | U19AG062682 | ASPirin in Reducing Events in the Elderly - eXTension | 000 | 5 | NIH | 10/26/2023 | $0 |
| | 2024 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 001 | 9 | NIH | 11/7/2023 | $0 |
| | 2024 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 001 | 9 | NIH | 11/7/2023 | $0 |
| | 2024 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01HS028829 | New Patient-centered Metric for Transplant Center Report Cards | 000 | 2 | AHRQ | 12/14/2023 | $0 |
| | 2024 | 2022 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | U01NS095926 | Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC | 000 | 5 | NIH | 12/28/2023 | $0 |
| | 2024 | 2022 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R34DA046078 | Implementation of Cessation Treatment in Community Based Mental Health Centers | 000 | 3 | NIH | 4/2/2024 | $0 |
| | 2024 | 2021 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | K24DK085153 | Prevalence and Impact of Frailty among Dialysis Patients | 001 | 11 | NIH | 1/8/2024 | -$149,045 |
| | 2024 | 2020 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | K24DK085153 | Prevalence and Impact of Frailty among Dialysis Patients | 000 | 10 | NIH | 1/8/2024 | -$20,250 |
| | 2024 | 2019 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 000 | 5 | NIH | 10/1/2023 | -$332,977 |
| | 2024 | 2018 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | RF1AG058729 | The Natural History of Cognitive Decline in Chronic Kidney Disease: Renal, Vascular and Alzheimer's Disease Contributions | 000 | 1 | NIH | 10/1/2023 | -$33,577 |
|
| Issue Date FY: 2023 ( Subtotal = $18,224,295 ) (Continued on the next page) |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | K08AI141761 | Memory T follicular helper cell kinetics and localization during recall immune responses to tetanus vaccination | 000 | 5 | NIH | 7/17/2023 | $194,370 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | U19AG062682 | ASPirin in Reducing Events in the Elderly - eXTension | 001 | 5 | NIH | 5/18/2023 | $2,500,000 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | U19AG062682 | ASPirin in Reducing Events in the Elderly - eXTension | 001 | 5 | NIH | 5/18/2023 | $5,532,026 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R03DK133553 | Expanding the Diabetes Homelessness Medication Support (D-Homes) program to Spanish speaking Hispanics | 000 | 2 | NIH | 7/17/2023 | $97,356 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | K23DK118117 | Improving medication adherence among people with diabetes who are homeless | 002 | 5 | NIH | 8/24/2023 | $162,374 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | K23DK118117 | Improving medication adherence among people with diabetes who are homeless | 001 | 5 | NIH | 8/24/2023 | $0 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | K23DK118117 | Improving medication adherence among people with diabetes who are homeless | 000 | 5 | NIH | 12/23/2022 | $162,374 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01DK137159 | A Learning Health System to increase organ donation and equity in populations experiencing health disparities | 000 | 1 | NIH | 9/1/2023 | $178,751 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01AI140303 | Gut Microbiota and Effect on Immune Suppressants in Transplantation | 000 | 4 | NIH | 1/24/2023 | $666,666 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R21AI171826 | Molecular and Cellular Analysis of Allograft Loss in Kidney Transplant Biopsies | 000 | 2 | NIH | 5/12/2023 | $158,680 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01DK135730 | Virtual coaching for potential kidney transplant candidates and their social support networks | 000 | 1 | NIH | 3/6/2023 | $262,716 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01DK134482 | Shared decision making for kidney transplant candidates to plan for an organ offer decision | 000 | 1 | NIH | 12/12/2022 | $270,280 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | K23MH124466 | Understanding STI and HIV prevention adherence among Kenyan women | 000 | 5 | NIH | 6/26/2023 | $187,812 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01HS028829 | New Patient-centered Metric for Transplant Center Report Cards | 000 | 2 | AHRQ | 8/1/2023 | $394,823 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 006 | 9 | NIH | 8/1/2023 | $0 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 004 | 9 | NIH | 2/24/2023 | $620,750 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 004 | 9 | NIH | 2/24/2023 | $4,520,407 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 007 | 9 | NIH | 9/28/2023 | $0 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 007 | 9 | NIH | 9/28/2023 | $0 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 005 | 9 | NIH | 7/10/2023 | $0 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 005 | 9 | NIH | 7/10/2023 | $0 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 006 | 9 | NIH | 8/1/2023 | $0 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UH3DE029973 | Effectiveness of Nicotine Replacement Therapy Sampling in Dental Practices | 003 | 4 | NIH | 8/21/2023 | $636,166 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01DA053608 | An evaluation of Beta-nicotyrine as a potential contributor to the abuse liability of e-cigarettes | 000 | 3 | NIH | 8/21/2023 | $330,726 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01HL160437 | Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa | 000 | 3 | NIH | 8/28/2023 | $530,979 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R01DA048899 | Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco products | 000 | 4 | NIH | 5/23/2023 | $641,826 |
| | 2023 | 2023 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | R13HS029436 | Research Conference to develop a national healthcare workforce wellness research agenda for AHRQ in the Learning Health System (LHS) program | 000 | 1 | AHRQ | 9/8/2023 | $50,000 |
| | 2023 | 2022 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | U19AG062682 | ASPirin in Reducing Events in the Elderly - eXTension | 000 | 4 | NIH | 1/13/2023 | $0 |
| | 2023 | 2022 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | U19AG062682 | ASPirin in Reducing Events in the Elderly - eXTension | 000 | 4 | NIH | 1/13/2023 | $0 |
| | 2023 | 2022 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | RF1AG079397 | Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias | 000 | 1 | NIH | 11/3/2022 | $82 |
| | 2023 | 2022 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | K23MH124466 | Understanding STI and HIV prevention adherence among Kenyan women | 003 | 4 | NIH | 6/26/2023 | $177,372 |
| | 2023 | 2022 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 000 | 8 | NIH | 11/10/2022 | $0 |
| | 2023 | 2022 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE | 701 PARK AVE | MINNEAPOLIS | MN | 55415-1623 | HENNEPIN | USA | UG1DA040316 | NorthStar Node of the Clinical Trials Network | 001 | 8 | NIH | 12/15/2022 | $0 |
|
